Stay updated on Quizartinib With Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the Quizartinib With Azacitidine in AML Clinical Trial page.

Latest updates to the Quizartinib With Azacitidine in AML Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov site revision number changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page shows a new site revision tag, updating from v3.6.6 to v3.7.0. This indicates a version update rather than a change to the trial data or history.SummaryDifference0.1%

- Check48 days agoChange DetectedThe page history now shows Revision: v3.6.6, replacing v3.6.5, indicating a new platform release. This update does not modify any study data or study-related content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe record history shows a new site revision, updating from v3.6.4 to v3.6.5, indicating a new build of the ClinicalTrials.gov interface.SummaryDifference0.1%

- Check84 days agoChange DetectedA new revision entry v3.6.4 is added and the previous v3.6.3 is removed in the record history, indicating a small platform update reflected in the study history page.SummaryDifference0.1%

- Check105 days agoChange DetectedThe page footer now shows Revision: v3.6.3, replacing Revision: v3.6.2. This reflects a new site release and does not alter trial data or page content.SummaryDifference0.1%

Stay in the know with updates to Quizartinib With Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Quizartinib With Azacitidine in AML Clinical Trial page.